Lubrizol Partners with IMCD to Expand Medical Polymers Business in China

By SKYSEVEN Chemical Technical Team · 2026-09-04

Share:

Lubrizol (Lubrizol) announced on September 2 that it will further deepen its cooperation in the field of medical polymers with IMCD, a global leader in specialty chemicals and ingredients distribution and formulation services. Under the agreement, IMCD will join the authorized distributor system of Lubrizol Medical Polymers business in East China.

This cooperation extends the successful cooperation experience accumulated by the two parties in the European and American markets to the Chinese market, further enhancing the availability of Lubrizol's medical-grade thermoplastic polyurethane (TPU) items, and helping global and regional medical device manufacturers greater easily obtain high-condition medical-grade TPU material solutions. The signing ceremony was held during the 2026 International Medical Device Design and Manufacturing methodology Exhibition (Medtec China).

Signing representatives of both parties (from left to right): Mr. Liu Yaqi, Asia Pacific Business Manager of Lubrizol Medical Polymers, and Ms. Huang Limin, Managing Director of IMCD China

With the continuous upgrading of China's medical device sector and the deepening of localized R & D and production layout of international medical device companies, the market demand to high-condition medical materials continues to grow. As an crucial gathering place to R & D and manufacturing of medical devices in China, East China has gathered rich innovative resources and many medical device companies, and the demand to high-condition medical materials is particularly strong.

As a key innovator in medical-grade TPU, Lubrizol has an sector-recognized portfolio of high-condition medical-grade TPU items covering a wide range of medical scenarios from immediate contact devices to prolonged implant applications. Through this cooperation, Lubrizol will combine IMCD's mature customer service capabilities and operating system to further enhance customer access to items and services, and better meet the evolving product research and manufacturing needs of the medical device sector.

Cai Jie, Senior Business Director, Lubrizol Asia Pacific, said, "This cooperation is not only an extension of our global partnership in the Chinese market, however also an crucial measure to Lubrizol to deepen our localization. By deepening our cooperation with IMCD, we will better respond to customer needs, support the entire process of medical device items from research to commercialization, and help customers speed up the process of bringing innovative items to market."

Previous

Bauhinia paint: more than 40 years of national brand, with hard core certification and innovative products to define the new standard of healthy home

Next

Tata Chemicals USA wins big North American soda contract

Quick inquiry

Create

Inquiry Sent

We will contact you soon